- June 16, 2021
- Posted by: Stratford Team
- Category: Business
Getty Images
During the Covid-19 pandemic, innovation in vaccines and medicines moved at an unprecedented pace. And that innovation required recruiting large numbers of people into clinical trials at rates that hadn’t been seen before. CVS Health, the corporate parent of the pharmacy chain that also owns insurance giant Aetna and other industries, helped leverage its contacts to the task: the company interacted with over 300,000 volunteers for the Covid-19 vaccine trials by connecting them with studies in proximity to them.
Last month, the company announced that it was beginning a new clinical trial services business, with the goal to merge innovation and experience to improve on overall participant experience for an increase in retention as well as research effectiveness.
The company will continue work on trials for Covid therapeutics and vaccines, but it’s going to move beyond that into other therapeutics as well by working with some of…
